Table 2 Alteration of vision and retinal and choroidal parameters following laser treatment.
Variables | Overall (meanā±āSD) | FAāguided PDT (meanā±āS) | IGCAāguided PDT (meanā±āSD) | Intergroup P-value | |
|---|---|---|---|---|---|
BCVA (logMAR) | Baseline | 0.49ā±ā0.40 | 0.34ā±ā0.26 | 0.56ā±ā0.43 | 0.132ā” |
4th month | 0.33ā±ā0.41 | 0.14ā±ā0.13 | 0.43ā±ā0.47 | 0.160ā | |
Change | Ā | āā0.19ā±ā0.05 | āā0.13ā±ā0.02 | Ā | |
Intragroup P-value | 0.005* | 0.001* | Ā | ||
choroidal area (mm2) | Baseline | 0.47ā±ā0.10 | 0.46ā±ā0.13 | 0.48ā±ā0.86 | 0.630§ |
4th month | 0.39ā±ā0.08 | 0.36ā±ā0.08 | 0.40ā±ā0.81 | 0.320ā | |
Change | Ā | 0.09ā±ā0.07 | 0.07ā±ā0.05 | Ā | |
Intragroup P-value | 0.001** | <ā0.001** | Ā | ||
PED area (mm2) | Baseline | 0.34ā±ā0.49 | 0.19ā±ā0.04 | 0.40ā±ā0.16 | 0.959ā” |
4th month | 0.19ā±ā0.39 | 0.07ā±ā0.08 | 0.24ā±ā0.46 | 0.930ā | |
Change | Ā | āā0.12ā±ā0.03 | āā0.16ā±ā0.14 | Ā | |
Intragroup P-value | 0.040* | 0.002* | Ā | ||
SFCT (µm) | Baseline | 354ā±ā54 | 338ā±ā38 | 363ā±ā60 | 0.251ā” |
4th month | 275ā±ā46 | 277ā±ā44 | 274ā±ā48 | 0.101ā | |
Change | Ā | 61ā±ā33 | 88ā±ā51 | Ā | |
Intragroup P-value | 0.001* | 0.001* | Ā | ||
CVI | Baseline | 81.16ā±ā5.43 | 81.00ā±ā4.44 | 81.25ā±ā5.98 | 0.896§ |
4th month | 77.45ā±ā5.04 | 76.16ā±ā4.60 | 78.13ā±ā5.23 | 0.174ā | |
Change | Ā | āā4.83ā±ā2.83 | āā3.12ā±ā3.15 | Ā | |
Intragroup P-value | 0.001** | 0.001** | Ā | ||
CMT (µm) | Baseline | 334ā±ā108 | 340ā±ā115 | 332ā±ā108 | 0.650ā” |
month | 202ā±ā63 | 195ā±ā37 | 207ā±ā74 | 0.478ā | |
Change | Ā | 144ā±ā109 | 124ā±ā67 | Ā | |
Intragroup P-value | 0.002* | 0.001* | Ā | ||